Laser capture microdissection
- 24 December 2025
- journal article
- Published by Springer Nature in Nature Reviews Methods Primers
- Vol. 5 (1)
Abstract
The tissue microenvironment was once viewed as an impossibly complex heterogeneous ecosystem. Today, tools and data analysis methods probe tissues at multiple resolution levels, from subpopulations to individual cells and individual molecules. Laser capture microdissection (LCM) was one of the first technologies enabling spatial molecular interrogation in tissues, enabling the extraction of precise regions of tissue for downstream acquisition and analysis of multiple classes of molecular analytes — including nucleic acids, proteins, metabolites and lipids. By physically isolating targeted cells or tissue compartments under microscopic visualization, LCM preserves spatial context for downstream multiomic profiling. The approach is agnostic to tissue type, molecular target and analytical tool, providing a powerful platform for spatially resolved analysis of tissue heterogeneity, microenvironment interactions and region-specific signatures. The attributes of LCM have drawn a large and diverse community of users who have imaginatively elevated the technology and its applications far beyond the early versions of LCM. In this Primer, we provide examples of how and when to use LCM and discuss its use with other spatial profiling platforms, providing an essential component of large-scale clinical research trials, revealing disease mechanisms and identifying predictors of therapeutic efficacy. Finally, we explore how the next generation of LCM and companion technologies will help to shape the personalized, designer therapies of the future.Keywords
This publication has 196 references indexed in Scilit:
- Gene Expression Profiling of Pancreatic Ductal Adenocarcinoma Arising From Intraductal Papillary Mucinous Neoplasms of the PancreasCancer Medicine, 2024
- A Multivalent DNA Nanoparticle/Peptide Hybrid Molecular Modality for the Modulation of Protein–Protein Interactions in the Tumor MicroenvironmentAdvanced NanoBiomed Research, 2024
- A secretory form of Parkin‐independent mitophagy contributes to the repertoire of extracellular vesicles released into the tumour interstitial fluid in vivoJournal of Extracellular Vesicles, 2022
- Association of Event-Free and Distant Recurrence–Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast CancerJAMA Oncology, 2020
- Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast CancerJAMA Oncology, 2020
- Treatment and Long-Term Risks for Patients With a Diagnosis of Ductal Carcinoma In Situ.JAMA Oncology, 2016
- Laser MicrodissectionCurrent Protocols in Molecular Biology, 2015
- The molecular pathology of breast cancer progressionThe Journal of Pathology, 2010
- Mass spectrometric analysis of formalin‐fixed paraffin‐embedded tissue: Unlocking the proteome withinProteomics, 2006
- Her‐2/neu and EGFR tyrosine kinase activation predict the efficacy of trastuzumab‐based therapy in patients with metastatic breast cancerInternational Journal of Cancer, 2005